Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1992 | 03-1992 | 12-1991 | 03-1991 | 12-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,885 | 87,923 | 8,350 | 10,312 | N/A |
| Marketable Securities | 84,982 | 17,496 | 19,449 | 0 | N/A |
| Other current assets | 936 | 770 | 226 | 71 | 0 |
| TOTAL | $103,803 | $106,189 | $28,025 | $10,383 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 4,531 | N/A | 1,882 | N/A |
| Other Non-Current Assets | 310 | 311 | 228 | 233 | 0 |
| TOTAL | $310 | $4,842 | $228 | $2,115 | $N/A |
| Total Assets | $106,565 | $108,690 | $30,199 | $12,498 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 531 | 371 | 152 | 342 | 0 |
| Accrued Expenses | 756 | 969 | 668 | 471 | N/A |
| Other current liabilities | 183 | 733 | 1,283 | 667 | N/A |
| TOTAL | $1,829 | $2,413 | $2,429 | $1,808 | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $732 | $687 | $503 | $481 | $N/A |
| Total Liabilities | $2,561 | $3,099 | $2,932 | $2,289 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 15 | 15 | 2 | 2 | N/A |
| Retained earnings | -16,030 | -14,271 | -12,915 | -9,754 | N/A |
| Other shareholders' equity | -2,920 | -2,461 | 37,465 | 19,913 | 0 |
| TOTAL | $104,004 | $105,591 | $27,267 | $10,209 | $N/A |
| Total Liabilities And Equity | $106,565 | $108,690 | $30,199 | $12,498 | $0 |